Immunostaging in carcinoma of prostate.
Immunostaging is a new method of assessing patients immunologically before and after immunotherapy. Twenty-eight patients with adenocarcinoma of the prostate were immunostaged independently by two investigators. There was a positive correlation between both immunostagings. There was also a positive correlation between the patient's immunostage and the clinical stage of his cancer.
D000230:Adenocarcinoma / Q000276:immunology*; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007158:Immunologic Techniques; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology*